Dr David Meya

Dr. Meya is an Associate Professor in the School of Medicine at the College of Health Sciences, Makerere University and holds an appointment as adjunct Associate Professor at the University of Minnesota. He has been involved in clinical research of central nervous system infections and complications, with a focus on HIV Immune Reconstitution Inflammatory syndrome (IRIS), an often deadly complication of antiretroviral therapy (ART) in persons living with AIDS . Dr. Meya has led epidemiological and translational research studies as well as randomised clinical trials in Uganda in collaboration with colleagues from the University of Minnesota.

Dr. Meya has a specific interest in public health interventions to prevent meningitis at population level and continues to advocate for cryptococcal antigen (CrAg) screening as a strategy to reduce deaths and hospitalisations from cryptococcal disease in Uganda.

He has been the Principal Investigator on NIH R01, CDC U01, and UK MRC grants and Industry-led research. Dr. Meya continues to be involved in advocacy to improve clinical care and outcomes in a predominantly HIV-infected patient population with limited resources for health. He has mentored over 50 students including PhD fellows, clinical fellows, Masters' students and undergraduate students from various countries.